Functionalised Graphene Quantum Dots for Cholesterol Detection in Human Blood Serum

Area of Science:

• Biomedical Technology
• Nanomedicine
• Analytical Chemistry

Background:

• Timely and accurate disease diagnosis is critical, especially with rising illness prevalence.
• Elevated blood cholesterol is a major risk factor for cardiovascular diseases (CVD), the leading global cause of death.
• Nanomedicine offers promising solutions for disease diagnosis and monitoring.

Purpose of the Study:

• To develop an easy and sensitive non-enzymatic method for cholesterol detection.
• To utilize fluorescent graphene quantum dots (GQs) for cholesterol sensing.
• To create a reliable probe for monitoring blood cholesterol levels to aid in CVD prevention.

Main Methods:

• Conjugation of digitonin with highly fluorescent graphene quantum dots (GQs).
• Development of a non-enzymatic based cholesterol detection assay using the GQD-digitonin probe.
• Evaluation of probe selectivity and performance in human blood serum samples.

Main Results:

• The digitonin-conjugated graphene quantum dots (GDG) probe demonstrated high sensitivity and selectivity for cholesterol detection.
• The probe proved reliable for cholesterol detection in human blood serum.
• The developed method is non-enzymatic, simplifying the detection process.

Conclusions:

• Digitonin-conjugated fluorescent graphene quantum dots (GDG) represent an efficient and selective probe for cholesterol sensing.
• This nanomedicine-based approach holds significant potential for reliable blood cholesterol monitoring.
• The developed probe can contribute to early detection and prevention strategies for cardiovascular diseases.